Serological Protection 5–6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes
Introduction: Although effective live attenuated yellow fever (YF) vaccines have been available for over 9 decades sporadic outbreaks continue to occur in endemic regions. These may be linked to several factors including epidemiological factors such as vector and intermediate host distribution or va...
Main Authors: | Olubukola T. Idoko, Cristina Domingo, Milagritos D. Tapia, Samba O. Sow, Christof Geldmacher, Elmar Saathoff, Beate Kampmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.577751/full |
Similar Items
-
The Yellow-Green Government and the Thorny Issue of Childhood Routine Vaccination
by: Mattia Casula, et al.
Published: (2018-10-01) -
The burden of viral respiratory infections in young children in low-resource settings
by: Uduak Okomo, et al.
Published: (2020-04-01) -
The thermal stability of yellow fever vaccines
by: Ricardo Ishak, et al.
Published: (1990-09-01) -
Monoclonal antibody-based serological detection of Citrus yellow vein clearing virus in citrus groves
by: Zhen LIU, et al.
Published: (2017-04-01) -
What Constitutes Protective Immunity Following Yellow Fever Vaccination?
by: Jolynne Mokaya, et al.
Published: (2021-06-01)